Back to search results

Trigger Point Injection for Low Back Myofascial Pain Syndrome

This study is looking at how well trigger point injections (TPI) work for people with low back pain caused by myofascial pain syndrome (MPS). MPS is a condition where pressure on sensitive points in your muscles (trigger points) causes pain in other parts of your body. Researchers want to see if TPI can reduce your pain and improve your ability to move. You might be able to join if you are 18 or older and have at least one trigger point in your lower back muscles. The study will measure how much your pain is reduced 30 minutes after treatment. The current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 180 participants. It is a randomized controlled trial, meaning participants will be assigned to different treatment groups by chance.
What's involved
You will have your pain and functional ability measured at the start, 30 minutes after treatment, and again 60-72 hours after treatment in the Emergency Department.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed up 60-72 hours after treatment to re-evaluate pain and functional ability.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04704297

Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial

Recruiting
PHASE4Ages 18+InterventionalTreatment
Madigan Army Medical Center
~180 participants
Updated 2021-01-12 on ClinicalTrials.gov
What's tested:Treatment of Myofascial Pain Syndrome in the low back. This intervention will be based on outcomes of the medications listed below.Evaluation of functional ability using a patient centered functional score known as the Modified Oswestry Disability Index (MODI). The intervention will be based on outcomes of medications below.Following up with participants 60-72 hours after treatment in the Emergency Department. This intervention will be based on outcomes of the medications listed below.

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Pain reduction
Measured over 30-minutes

Conditions

Low Back Pain
Myofascial Pain Syndrome Lower Back

Explore related trials

Lower Back PainMyofascial pain syndrome

Where it's being run

1 sites across 1 states
Washington1

Study leadership

  • Joshua J Oliver, MD · PRINCIPAL_INVESTIGATOR · Madigan AMC

Who to contact

Joshua J Oliver, MD
[email protected]
(360) 393-9024
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Pain reduction30-minutes

    To determine which of three treatments is the superior treatment for myofascial pain syndrome (MPS) of the low back. The three treatments are standard therapy (ST), ST plus trigger point injections (TPI) with 8 mL of 0.5% Bupivacaine, and ST plus TPI with 8 mL of normal saline NS. To reach superiority a treatment will have to decrease pain by 1.5 cm more than the other treatments, measured before treatment and 30-minutes following treatment on a 10 cm visual analog scale (VAS). The units of measurement are centimeters (cm) on a VAS.